As of 2024-12-12, the EV/EBITDA ratio of AngioDynamics Inc (ANGO) is -49.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANGO's latest enterprise value is 315.13 mil USD. ANGO's TTM EBITDA according to its financial statements is -6.36 mil USD. Dividing these 2 quantities gives us the above ANGO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 17.9x | 16.8x |
| Forward P/E multiples | 15.3x - 22.5x | 18.0x |
| Fair Price | (1.04) - (1.45) | (1.37) |
| Upside | -111.4% - -115.9% | -115.0% |
| Date | EV/EBITDA |
| 2024-12-09 | -46.50 |
| 2024-12-06 | -36.08 |
| 2024-12-05 | -36.72 |
| 2024-12-04 | -36.98 |
| 2024-12-03 | -36.72 |
| 2024-12-02 | -36.98 |
| 2024-11-29 | -35.63 |
| 2024-11-27 | -36.21 |
| 2024-11-26 | -36.02 |
| 2024-11-25 | -36.02 |
| 2024-11-22 | -34.99 |
| 2024-11-21 | -35.76 |
| 2024-11-20 | -34.42 |
| 2024-11-19 | -34.29 |
| 2024-11-18 | -35.31 |
| 2024-11-15 | -34.87 |
| 2024-11-14 | -35.12 |
| 2024-11-13 | -36.02 |
| 2024-11-12 | -36.98 |
| 2024-11-11 | -38.89 |
| 2024-11-08 | -37.36 |
| 2024-11-07 | -37.04 |
| 2024-11-06 | -38.70 |
| 2024-11-05 | -36.02 |
| 2024-11-04 | -34.42 |
| 2024-11-01 | -34.04 |
| 2024-10-31 | -34.10 |
| 2024-10-30 | -35.63 |
| 2024-10-29 | -35.70 |
| 2024-10-28 | -34.48 |
| 2024-10-25 | -34.36 |
| 2024-10-24 | -36.66 |
| 2024-10-23 | -36.98 |
| 2024-10-22 | -37.81 |
| 2024-10-21 | -33.14 |
| 2024-10-18 | -32.18 |
| 2024-10-17 | -31.86 |
| 2024-10-16 | -31.10 |
| 2024-10-15 | -31.80 |
| 2024-10-14 | -32.57 |
| 2024-10-11 | -32.25 |
| 2024-10-10 | -30.59 |
| 2024-10-09 | -30.20 |
| 2024-10-08 | -28.92 |
| 2024-10-07 | -30.33 |
| 2024-10-04 | -30.33 |
| 2024-10-03 | -32.06 |
| 2024-10-02 | -40.24 |
| 2024-10-01 | -40.11 |
| 2024-09-30 | -41.07 |